0001213900-20-022342.txt : 20200814
0001213900-20-022342.hdr.sgml : 20200814
20200814172147
ACCESSION NUMBER: 0001213900-20-022342
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200812
FILED AS OF DATE: 20200814
DATE AS OF CHANGE: 20200814
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Loughlin Steve
CENTRAL INDEX KEY: 0001615840
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36374
FILM NUMBER: 201106690
MAIL ADDRESS:
STREET 1: 955 HARTMAN RUN ROAD
CITY: MORGANTOWN
STATE: WV
ZIP: 26507
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Actinium Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001388320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 880378336
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 275 MADISON AVENUE, 7TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 646-677-3875
MAIL ADDRESS:
STREET 1: 275 MADISON AVENUE, 7TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
FORMER COMPANY:
FORMER CONFORMED NAME: Cactus Ventures, Inc.
DATE OF NAME CHANGE: 20070130
4
1
ownership.xml
X0306
4
2020-08-12
0
0001388320
Actinium Pharmaceuticals, Inc.
ATNM
0001615840
O'Loughlin Steve
C/O ACTINIUM PHARMACEUTICALS, INC.
275 MADISON AVENUE, 7TH FLOOR
NEW YORK
NY
10016
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
9.55
2020-08-12
4
A
0
59066
0
A
2030-08-12
Common Stock
59066
59066
D
This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant.
Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from August 12, 2020 until fully vested.
/s/ Steve O'Loughlin
2020-08-14